Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here

Request a Proposal  
Oncology[Optimized]

Oncology CRO Services

Offering Global Oncology CRO Services Focused on Early Phase Oncology Research.

Request a Proposal

Oncology[Optimized]

Oncology and hematology are highly nuanced areas of research because every indication requires unique solutions. Our oncology CRO services team has the deep expertise to expedite early phase trials and support emerging biotech. 

We go the distance - to help you create a healthier world. 

Request A Proposal

Oncology By The Numbers

Pharm-Olam
0
Studies
Pharm-Olam
0
Sites
Pharm-Olam
0
Patients

An Immuno-Oncology Case Study

Phase I Solid Tumor PD-1 Inhibitor Study Enrolled 78 Days Early

Pharm-Olam was hired by a sponsor to run a PD-1 Inhibitor Phase I oncology study in solid tumor patients.  The study moved swiftly and we completed enrollment 78 days early.  

Read The Case Study

PD-1-Case-study-graphic-sm

 

An Immuno-Oncology Case Study

Phase I Solid Tumor PD-1 Inhibitor Study Enrolled 78 Days Early

Pharm-Olam was hired by a sponsor to run a PD-1 Inhibitor Phase I oncology study in solid tumor patients.  The study moved swiftly and we completed enrollment 78 days early.  

Read The Case Study

Oncology CRO Expertise – Working for You

Expedited Early Phase

Accelerating early phase research is critical to sponsors and patients. As an oncology CRO, we have invested in advantageous site and vendor relationships with process optimizations and checkpointed cohort management techniques to expedite your early-phase study. We know how to avoid bottlenecks and deliver your study on time.

Oncology Aligned Staff

At Pharm-Olam, we maintain therapeutically-aligned staff with deep expertise in Oncology. From solid tumor to liquid tumor, our oncology CRO staff have the expertise you need to go the distance.

Staff with Oncology study expertise.

  • 90% of our Project Managers
  • 89% of our CRAs

Built for Small & Emerging

Pharm-Olam has championed small pharma and biotech companies since the earliest developments in the field. Some 74% of our clients have always been small and emerging pharma and biotechs. We continue those efforts today.  With Pharm-Olam, you will find an agile CRO always focused on finding trial specific solutions to accelerate your study execution.  We go the distance – helping you create a healthier world. 

Hematology CRO Services

Our Hematology experience includes liquid tumor expertise as well as numerous non-cancerous hematology diseases.  From rare hematology disorders to common diseases, we have gone the distance for our patients and are ready to support your hematology drug development.

Hematology CRO Services >>

Pharm-Olam

Oncology Expertise You Can Depend On

When you choose a team with the right kind of therapeutic experience, you set your study up for success. For more than 20 years, we have specialized in rare and orphan disease clinical trials supporting global research across a wide variety of indications including:

Brain
Breast
Colorectal
Hepatocellular
Leukemia
Lung
Lymphoma
Pancreatic
Prostate

Need a partner for your next oncology-hematology study?

Our team is dedicated and ready to assist.  Talk with our team today.  

Please choose one.

Contact Us